Patent: (prefix with "WO" like WO6078908)
  1. WIPO
    Data
    Cmpds
    HGNC*
    WIPO Title
    Organization
    Deposition
    Downloads
  2. 110
    3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGONISTS
    MERCK SHARP & DOHME LLC
    10/05/22
  3. 32
    POLYHETEROCYCLIC GLP-1 R MODULATING COMPOUNDS
    GILEAD SCIENCES, INC.
    10/05/22
  4. 31
    SARS-COV-2 MPRO INHIBITOR COMPOUNDS
    HEPTARES THERAPEUTICS LIMITED
    10/05/22
  5. 49
    1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER
    GENENTECH, INC.
    08/07/22
  6. 42
    1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXYPYRROLIDINE-2-CARBOXA|MIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA
    GENENTECH, INC.
    08/07/22
  7. 56
    7-AZOLE SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1
    MERCK SHARP & DOHME LLC
    08/07/22
  8. 80
    CYCLOPENTATHIOPHENE CARBOXAMIDE DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS
    BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    08/07/22
  9. 47
    DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1
    MERCK SHARP & DOHME LLC
    08/07/22
  10. 14
    N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
    BAYER AKTIENGESELLSCHAFT
    08/07/22
  11. 34
    PYRAZOLE DERIVATIVES ASR ET KINASE INHIBITORS
    ELI LILLY AND COMPANY
    08/07/22
  12. 125
    SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE
    JANSSEN PHARMACEUTICA NV
    08/07/22
  13. 384
    7-PHENYL SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1
    MERCK SHARP & DOHME LLC
    07/22/22
  14. 61
    HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE
    AMGEN INC.
    07/21/22
  15. 226
    INTERLEUKIN-17 INHIBITORS
    NOVARTIS AG
    07/21/22
  16. 236
    N-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
    MERCK SHARP & DOHME LLC
    07/21/22
  17. 219
    SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS
    BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    07/21/22
  18. 68
    SUBSTITUTED MORPHOLINE COMPOUNDS
    GENENTECH, INC.
    07/21/22
  19. 19
    ANTIVIRAL HETEROARYL KETONE DERIVATIVES
    PFIZER INC.
    06/09/22
  20. 80
    NOVEL CORONAVIRUS MAIN PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF
    SICHUAN UNIVERSITY
    06/09/22
  21. 29
    COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS
    NOVARTIS AG
    05/24/22
  22. 71
    PHOSPHOLIPID COMPOUNDS AND USES THEREOF
    GILEAD SCIENCES, INC.
    05/24/22
  23. 229
    SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER
    THE BROAD INSTITUTE, INC.
    05/24/22
  24. 68
    SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER
    THE BROAD INSTITUTE, INC.
    05/24/22
  25. 294
    TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
    BRISTOL-MYERS SQUIBB COMPANY
    05/24/22
  26. 83
    AMINOIMIDAZOLE FPR2 AGONISTS
    BRISTOL-MYERS SQUIBB COMPANY
    05/02/22
  27. 172
    CYCLIN-DEPENDENT KINASE 7 (CDK7) NON-COVALENT INHIBITORS
    JANSSEN PHARMACEUTICA NV
    05/02/22
  28. 25
    DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    JANSSEN BIOTECH, INC.
    05/02/22
  29. 6
    DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    JANSSEN BIOTECH, INC.
    05/02/22
  30. 8
    DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    JANSSEN BIOTECH, INC.
    05/02/22
  31. 141
    PREPARATION OF BENZIMIDAZOLONE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
    MERCK SHARP & DOHME CORP.
    05/02/22
  32. 168
    PREPARATION OF OXINDOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
    MERCK SHARP & DOHME CORP.
    05/02/22
  33. 100
    Aminocarbamoyl compounds for the treatment of viral infections
    F. Hoffmann-La Roche Ag
    03/30/22
  34. 178
    Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections
    Insilico Medicine Ip Limited
    01/27/22
  35. 44
    Compounds and method of treating covid-19
    Pfizer Inc.
    01/13/22
  36. 3
    Compounds and methods for the treatment of covid-19
    Pfizer Inc.
    01/13/22
  37. 94
    Nitrile-containing antiviral compounds
    Pfizer Inc.
    01/13/22
  38. 12
    Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
    Pfizer Inc.
    01/31/21
  39. 61
    Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
    Pfizer Inc.
    10/17/20
* for human-derived proteins